drugset / Trial / NCT05686005

Tranexamic Acid in Functional Endoscopic Sinus Surgery

NCT05686005

Phase 4 Completed 159 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of the study is to compare the effect of oral tranexamic acid vs. intravenous in decreasing bleeding and improving the field during FESS.

Timeline

Start
2022-12-03
Primary completion
2023-04-29
Completion
2023-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 15 mg/kg Oral
Comparator Tranexamic Acid Small molecule 2 g Oral

Indications

No indication recorded.